GOLDMAN SACHS GROUP INC - RAIN THERAPEUTICS INC ownership

RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 58 filers reported holding RAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of RAIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$24,504
-91.4%
28,434
-88.1%
0.00%
Q2 2023$286,339
-61.5%
238,616
+180.5%
0.00%
Q1 2023$743,617
+1227.9%
85,082
+744.7%
0.00%
Q2 2022$56,000
-33.3%
10,072
-39.5%
0.00%
Q1 2022$84,000
-34.9%
16,655
+65.9%
0.00%
Q4 2021$129,00010,0380.00%
Other shareholders
RAIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,571,379$20,239,0003.93%
Cormorant Asset Management, LP 2,326,660$29,967,0001.78%
BVF INC/IL 2,957,807$38,097,0001.38%
Boxer Capital, LLC 1,175,000$15,134,0000.59%
Perceptive Advisors 4,967,238$63,978,0000.49%
LUMINUS MANAGEMENT LLC 137,428$1,770,0000.42%
Logos Global Management LP 245,161$3,158,0000.33%
Old Well Partners, LLC 13,383$172,0000.11%
Lumina Fund Management LLC 6,000$77,0000.02%
Woodline Partners LP 119,700$1,542,0000.02%
View complete list of RAIN THERAPEUTICS INC shareholders